Within the hematopoietic malignant tumors, ectopic expression of MerTK has been reported in pre-B cell acute lymphoblastic leukemia (B-ALL), T cell acute lymphoblastic leukemia (T-ALL), and acute myeloid leukemia (AML) [15–17]. Here, MERTK is linked to acute myeloid leukemia.